Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series.

Autor: Kanda Y; Division of Hematology, Department of Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-Shi, Tochigi-Ken, 329-0498, Japan. ycanda-tky@umin.ac.jp., Mori T; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.; Department of Hematology, Tokyo Medical and Dental University, Tokyo, Japan., Narita A; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan., Wolter KD; Pfizer Inc, New York, NY, USA., Yoshimatsu H; Pfizer R&D Japan, Tokyo, Japan., Nishimura K; Pfizer R&D Japan, Tokyo, Japan.
Jazyk: angličtina
Zdroj: International journal of hematology [Int J Hematol] 2023 Mar; Vol. 117 (3), pp. 469.
DOI: 10.1007/s12185-023-03543-9
Databáze: MEDLINE
Externí odkaz: